Skip to content
Use caution Medical device recall · FDA · Published August 29, 2022

Ossur Power Knee Recall: Battery May Dislodge

Ossur recalls Power Knee models PKA10003 and PKA01001L/T with battery that may dislodge. Affected users should contact Ossur for details.

🇺🇸 FDA recall #Z-1821-2022Medical deviceOssur ›
Take action

Contact the company

Recalling firmOssur Americas27051 Towne Centre Dr · Foothill Ranch, CA 92610-2804
✎ GovInfoNow plain-language explainer

What happened, in plain English

Ossur is recalling specific Power Knee models where the battery might become loose. This could cause the device to malfunction or become unsafe during use. Read more at govinfonow.com/recall/60118-ossur-power-knee-recall-battery-may-dislodge.

Source Summary by GovInfoNow · govinfonow.com/recall/60118-ossur-power-knee-recall-battery-may-dislodge · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1821-2022

Cite this page

“Ossur Power Knee Recall: Battery May Dislodge.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60118-ossur-power-knee-recall-battery-may-dislodge. Based on FDA recall #Z-1821-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1821-2022%22&limit=1).

Why it’s dangerous

The battery in these models may become dislodged, potentially causing the device to malfunction or become unsafe during use. This could lead to the device not functioning properly or causing injury if it becomes loose.

Who’s affected

Users of Ossur Power Knee devices with model numbers PKA10003, PKA01001L, or PKA01001T are affected. People who rely on these devices for mobility are most at risk.

How to tell if you have this one

Check for model numbers PKA10003, PKA01001L, or PKA01001T on your Power Knee device. Serial numbers listed in the recall include HF511081 through HF511378.

  • Brand
    Ossur
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Ossur

    Reach out to Ossur directly for assistance with the recall. They will provide instructions on how to address the issue.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 36 states.

Alaska: nationwideAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: nationwideIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: nationwideKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “U.S. Nationwide distribution in the states of AL, AR, AZ, CA, FL, GA, HI, IA, IL, IN, LA, MA, MD, MI, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OR, PA, SC, SD, TN, TX, VA, VT, WA and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Aug 29, 202212. FDA classified it Class II: Sep 28, 202223. Published in FDA’s Enforcement Report: Oct 5, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1821-2022 (August 29, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1821-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA